Shots: AbCellera to receive upfront, pre-clinical, clinical & commercial milestones including research payments for the non-COVID-19 targets plus royalties on future sales. Eli Lilly to get rights to develop and […]readmore
Tags : Abs
Shots: Adaptive to expand its platform for selection of B cell receptors of recovered patients from COVID-19. Amgen will utilize its Ab engineering and drug development capabilities to select and […]readmore
Shots: The total deal value is $362M and under this agreement, Samsung is expected to commence its manufacturing till Oct in Plant 3, with expected commercialization in early 2021. Additionally, […]readmore
Shots: AbCellera to receive technology access fee, milestones and royalties on the development and commercialization of pre-cliniocal candidates & will develop Abs for Denali’s eight targets for neurological disorders On […]readmore